Genetic and morphological aspects of the enterocutaneous fistula development

Keywords: enterocutaneous fistula, matrix metalloproteinase-2, tissue inhibitors of metalloproteinase-2, gene polymorphism, immunohistochemical markers.


Objective. To analyze the frequency of polymorphic variants of matrix metalloproteinase-2 (C-1306 → T) and tissue inhibitors of metalloproteinase-2 (G303 → A) genes in patients with enterocutaneous fistulas and to identify the connection with morphological changes of connective tissue.

Materials and methods. The object of the study comprises 24 patients with enterocutaneous fistula who were treated in the Shalimov National Institute of Surgery and Transplantology during 2016-2020. Laboratory, genetic, histological studies and statistical analysis were performed.

Results. As a result of genetic and statistical analysis of the matrix metalloproteinase-2 (C-1306→T) and tissue inhibitors of metalloproteinase-2 (G303→A) gene single nucleotide polymorphisms, genotype variants have been identified that are associated with the risk of enterocutaneous fistula development. Immunohistochemical examination of tissues with monoclonal antibodies to α-smooth muscle actin (α-SMA) revealed uneven, focal expression in smooth muscle differentiation cells and fibroblasts. Examination with monoclonal antibodies to Collagen IV there is a moderate positive expression in the basement membrane of blood vessels, in smooth muscle cells of the muscular layer of the vascular wall, in areas of connective tissue.

Conclusion. Enterocutaneous fistula is 1,5 times more common in carriers of homozygous GG genotype of the tissue inhibitors of metalloproteinase-2 (G303→A) gene and twice less common in heterozygotes GA (25% vs. 40%, p=0,057). Carriers of minor homozygotes of AA genotype in the group with enterocutaneous fistula were not detected, while a similar genotype in the control group was found in 10% of cases. Immunohistochemical examination of small and large intestine tissues with monoclonal antibodies to Collagen IV and α-SMA revealed signs of pathological connective tissue remodeling.

Author Biographies

Yu. Usenko, Shalimov National Institute of Surgery and Transplantology, Kyiv

Usenko Olexandr Yu., MD, Dsci(Med), Professor;
Director of the Shalimov National Institute of Surgery and Transplantology,
Head of the department of Toracoabdominal Surgery;
Kyiv, 30 Heroiv Sevastopolia str.
+38 (044) 454 70 50

Ya. Yu. Voitiv, Shalimov National Institute of Surgery and Transplantology, Kyiv

Voitiv Yaroslav Yu. - MD, PhD (Med), Associate Professor, Surgeon
Department of Torakoabdominal Surgery
Shalimov National Institute of Surgery and Transplantology,
30 Heroiv Sevastopolia Str., 03680, Kyiv, Ukraine
+38 044 497 1374


Schecter WP, Hirshberg A, Chang DS, Harris HW, Napolitano LM, Wexner SD, Dudrick SJ. Enteric fistulas: principles of management. J Am Coll Surg. 2009 Oct;209(4):484-91. doi: 10.1016/j.jamcollsurg.2009.05.025. Epub 2009 Jul 2. PMID: 19801322.

Teixeira PG, Inaba K, Dubose J, Salim A, Brown C, Rhee P, et al. Enterocutaneous fistula complicating trauma laparotomy: a major resource burden. Am Surg. 2009 Jan;75(1):30-2. doi: 10.1177/000313480907500106. PMID: 19213393.

Schein M, Decker GA. Postoperative external alimentary tract fistulas. Am J Surg. 1991 Apr;161(4):435-8. doi: 10.1016/0002-9610(91)91107-t. PMID: 1827960.

Holzheimer RG, Mannick JA, editors. Surgical treatment—evidence-based and problem-oriented. München: W. Zuckschwerdt Verlag GmbH; 2001. 843 p. ISBN-10: 3-88603-714-2.

Whelan JF Jr, Ivatury RR. Enterocutaneous fistulas: an overview. Eur J Trauma Emerg Surg. 2011 Jun;37(3):251-8. doi: 10.1007/s00068-011-0097-2. Epub 2011 Mar 29. PMID: 26815107.

Williams LJ, Zolfaghari S, Boushey RP. Complications of enterocutaneous fistulas and their management. Clin Colon Rectal Surg. 2010 Sep;23(3):209-20. doi: 10.1055/s-0030-1263062. PMID: 21886471; PMCID: PMC2967321.

Lloyd DA, Gabe SM, Windsor AC. Nutrition and management of enterocutaneous fistula. Br J Surg. 2006 Sep;93(9):1045-55. doi: 10.1002/bjs.5396. PMID: 16804873.

Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am. 1996 Oct;76(5):1009-18. doi: 10.1016/s0039-6109(05)70495-3. PMID: 8841361.

van Haaften WT, Mortensen JH, Karsdal MA, Bay-Jensen AC, Dijkstra G, Olinga P. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease. Aliment Pharmacol Ther. 2017 Jul;46(1):26-39. doi: 10.1111/apt.14092. Epub 2017 May 8. PMID: 28481042; PMCID: PMC6221070.

Stumpf M, Junge K, Wendlandt M, Krones C, Ulmer F, Klinge U, Schumpelick V. Risikofaktoren für das Auftreten postoperativer Anastomoseninsuffizienzen nach kolorektalen Resektionen [Risk factors for anastomotic leakage after colorectal surgery]. Zentralbl Chir. 2009 Jun;134(3):242-8. German. doi: 10.1055/s-0028-1098773. Epub 2009 Jun 17. PMID: 19536719.

Meijer MJ, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Hommes DW, Verspaget HW. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol. 2007 Jun 7;13(21):2960-6. doi: 10.3748/wjg.v13.i21.2960. PMID: 17589947; PMCID: PMC4171149.

Chen J, Ren JA, Han G, Gu GS, Wang GF, Wu XW, et al. Polymorphism of heat shock protein 70-2 and enterocutaneous fistula in Chinese population. World J Gastroenterol. 2014 Sep 21;20(35):12559-65. doi: 10.3748/wjg.v20.i35.12559. PMID: 25253958; PMCID: PMC4168091.

Voitiv YaYu, Dzhemiliev A. Connective tissue pathology as a risk factor for intestinal fistula development. East European Scientific Journal. 2019;(12):57-61.

Dabbs D, editor. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, 4th Edition. Saunders Elsevier; 2014: 960 p. ISBN-13 : 978-1455744619.

How to Cite
Usenko, Y., & Voitiv, Y. Y. (2020). Genetic and morphological aspects of the enterocutaneous fistula development. Klinicheskaia Khirurgiia, 87(7-8), 38-42.
General Problems of Surgery